Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer
Clinical trial NCT03941093 · COMPLETED
Trial details
- NCT number
- NCT03941093
- Sponsor
- Kyntra Bio
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-10
- Primary completion
- 2024-06-11
- Enrollment
- 284
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.